E-LIB Suche - Ergebnisse für: Carde, P.

1

PROGNOSTIC VALUE OF IMMUNOHISTOCHEMICAL MARKERS IN STAGE II..:

Canioni, D. ; Brice, P. ; Bologna, S....
Hematological Oncology. 35 (2017) S2 - p. 162-163 , 2017

Link: https://doi.org/10.1002/..

2

First-line escalated BEACOPP does not hinder stem cell coll..:

Ghez, D ; Fortpied, C ; Mounier, N...
Bone Marrow Transplantation. 52 (2016) 2 - p. 310-312 , 2016

Link: https://doi.org/10.1038/..

3

Telomere shortening: a new prognostic factor for cardiovasc..:

M'kacher, R. ; Girinsky, T. ; Colicchio, B....
Radiation Protection Dosimetry. 164 (2014) 1-2 - p. 134-137 , 2014

Link: https://doi.org/10.1093/..

4

OC-0055: Telomere shortening in lymphocytes of Hodgkin lymp..:

M'kacher, R. ; Girinsky, T. ; Colicchio, B....
Radiotherapy and Oncology. 111 (2014) - p. S20 , 2014

Link: https://doi.org/10.1016/..

5

Clinical achievements of the EORTC Lymphoma Group and aspec..:

Meijnders, P. ; Carde, P. ; Girinsky, T....
European Journal of Cancer Supplements. 10 (2012) 1 - p. 105-111 , 2012

Link: https://doi.org/10.1016/..

6

OP32 Late effects in survivors of Hodgkin's lymphoma:

Carde, P.
Leukemia Research. 31 (2007) - p. S47 , 2007

Link: https://doi.org/10.1016/..

7

P215 - Dermatose neutrophilique associée à un mycosis fongo..:

Riaux, A. ; Bosq, J. ; Wechsler, J....
Annales de Dermatologie et de Vénéréologie. 132 (2005) - p. 202-203 , 2005

Link: https://doi.org/10.1016/..

8

Long-term efficacy of the CHVmP/BV regimen used for aggress..:

Moser, E.C. ; Noordijk, E.M. ; van Glabbeke, M....
European Journal of Cancer. 40 (2004) 4 - p. 474-480 , 2004

Link: https://doi.org/10.1016/..

9

Baseline and treatment-induced chromosomal abnormalities in..:

M'kacher, R ; Girinsky, T ; Koscielny, S...
International Journal of Radiation Oncology*Biology*Physics. 57 (2003) 2 - p. 321-326 , 2003

Link: https://doi.org/10.1016/..

10

Blastoid mantle cell lymphoma:

M'kacher, R ; Farace, F ; Bennaceur-Griscelli, A...
Cancer Genetics and Cytogenetics. 143 (2003) 1 - p. 32-38 , 2003

Link: https://doi.org/10.1016/..

11

Premature chromosome condensation associated with fluoresce..:

M'kacher, R. ; Violet, D. ; Aubert, B....
Radiation Protection Dosimetry. 103 (2003) 1 - p. 35-39 , 2003

Link: https://doi.org/10.1093/..

12

The achievements of the EORTC Lymphoma Group:

Raemaekers, J ; Kluin-Nelemans, H ; Teodorovic, I...
European Journal of Cancer. 38 (2002) - p. 107-113 , 2002

Link: https://doi.org/10.1016/..

13

Standard Chemotherapy With or Without High-Dose Chemotherap..:

Kluin-Nelemans, H. C. ; Zagonel, V. ; Anastasopoulou, A....
JNCI Journal of the National Cancer Institute. 93 (2001) 1 - p. 22-30 , 2001

Link: https://doi.org/10.1093/..

14

Maladie de Hodgkin: pourquoi faut-il la radiothérapie dans ..:

Carde, P.
Cancer/Radiothérapie. 3 (1999) - p. 137s-141s , 1999

Link: https://doi.org/10.1016/..

15

Le rôle de la radiothérapie dans les formes localisées de m..:

Cosset, J.M. ; Fermé, C. ; Henry-Amar, M..
Cancer/Radiothérapie. 3 (1999) 2 - p. 112-118 , 1999

Link: https://doi.org/10.1016/..